Clinical Investigation

You have free access to this content

Evaluation of Rosiglitazone Administration on Cardiovascular Function in Severe Obesity

  1. Amelia Brunani MD1,*,
  2. Antonio Liuzzi MD1,
  3. AnnaMaria Titon MD2,
  4. Salvatore Graci MD1,
  5. Giovanna Castagna PhD3,
  6. Gian Carlo Viberti MD4,
  7. Luca A. Gondoni MD2

Article first published online: 18 DEC 2008

DOI: 10.1002/clc.20339

Issue

Clinical Cardiology

Clinical Cardiology

Volume 31, Issue 12, pages 602–606, December 2008

Additional Information

How to Cite

Brunani, A., Liuzzi, A., Titon, A., Graci, S., Castagna, G., Viberti, G. C. and Gondoni, L. A. (2008), Evaluation of Rosiglitazone Administration on Cardiovascular Function in Severe Obesity. Clin Cardiol, 31: 602–606. doi: 10.1002/clc.20339

Author Information

  1. 1

    Department of Internal Medicine

  2. 2

    Unit of Cardiac Rehabilitation

  3. 3

    Laboratory Ospedale San Giuseppe, IRCCS, Istituto Auxologico Italiano, Verbania, Italy

  4. 4

    Department of Diabetes and Endocrinology, GKT School of Medicine, Guy's Hospital, King's College of London, London, United Kingdom

*Ospedale San Giuseppe Piancavallo 28900 Verbania, Italy

Publication History

  1. Issue published online: 18 DEC 2008
  2. Article first published online: 18 DEC 2008
  3. Manuscript Accepted: 2 NOV 2007
  4. Manuscript Received: 19 SEP 2007

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

Get PDF (105K)

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Selcuk Pala, Özlem Esen, Mustafa Akçakoyun, Gökhan Kahveci, Ramazan Kargın, Kürşat Tigen, Tansu Karaahmet, Göksel Açar, Ali Metin Esen, Cevat Kırma, Rosiglitazone, but Not Pioglitazone, Improves Myocardial Systolic Function in Type 2 Diabetic Patients: A Tissue Doppler Study, Echocardiography, 2010, 27, 5
    Direct Link:
Get PDF (105K)